Table 1.
Outcome measures | Baseline | During spinal-to-sciatic DCS | During sciatic-to-spinal DCS | Overall (ANOVA) |
p value (post hoc comparison) |
||
---|---|---|---|---|---|---|---|
F value | p value | Baseline vs spinal-to-sciatic DCS | Baseline vs sciatic-to-spinal DCS | ||||
Nerve discharges in controls (spikes/s) | 21.8 ± 1.3 | 10.8 ± 1.8 | 46.5 ± 0.7 | 137.0 | <0.001* | <0.002* | <0.002* |
Nerve discharges in mice with SCI (spikes/s) | 51.0 ± 9.9 | 29.5 ± 2.9 | 138.4 ± 22.7 | 17.3 | <0.001* | <0.05* | <0.05* |
Slope of muscle resistance in controls (g/s) | 80.2 ± 16.4 | 68.9 ± 25.2 | 177.9 ± 30.9 | 6.3 | <0.02* | <0.03* | <0.03* |
Slope of muscle resistance in mice with SCI (g/s) | 359.4 ± 0.4 | 272.3 ± 8.5 | 676.5 ± 89.8 | 14.1 | <0.001* | <0.03* | <0.03* |
Values are given as the mean ± SD, unless otherwise stated.
*Significant value.